Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: RO6839921
Total 1 results
Hoffmann-La Roche
Completed
A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.
Neoplasms, Myelogenous Leukemia, Acute
United States, Canada
Sponsors and Collaborators
Clinique Devron, Dijon
Sociedad Española de Trasplante
Irina Jaeger
PT. Daewoong Infion
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary
Roxane Laboratories
Aivita Biomedical, Inc.
Neil Kleiman, MD
Yazan Saleh Rajab Hammad
Prostate Cancer UK
Vital Signs Solutions Ltd
Vietnam Veterans of America Foundation
BMI Southend Hospital
Ardeypharm GmbH
Colorado Mesa University
Xiangcheng Zhang
Homology Medicines, Inc
CliPSBnC
Sinovac Life Sciences Co., Ltd.
The Affiliated Third Hospital of Jiangsu University
View Full List
Medical Conditions
B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
Colorectal Cancer, Somatic (Diagnosis)
Respiration; Sleep Disorder
Low Resting Position of Tongue
Breast Cancer (Early Breast Cancer)
Solid Malignancy
Droopy Eyelid
Post-Infectious Parkinsonism
Elevated IgE Level
Newly Diagnosed Secondary or High Risk AML
Comparison of Images From RDSL Existing Slit Lamp Technology
Stage IV Mucoepidermoid Carcinoma of the Oral Cavity
Rhegmatogenous Retinal Detachments
NREM Parasomnia
Agitation in Adolescents and Young Adults With ASD
Epiphrenic Diverticula
CKD Stage 3/4
Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Post Ablation Syndrome
Refractory Plasmablastic Lymphoma
View Full List
Drug Interventions
SDR-PEP Rifampicin
Dienogest 2.0 mg Test Drug
PREG 300/500 mg
Experimental: Vitamin D3 100,000 IU
PEG-rhGH with present preparation (R)
JNJ-63723283
Livalo® IR
Ravulizumab
Naltrexone SR 32 mg/Bupropion SR 360 mg /day
Erlotinib
AK109+AK104
Bupropion
Physiological saline
Piperacillin-Tazobactam
Bleomycin
Ranibizumab Injection [Lucentis]
Elafibranor 80mg
0.75% ropivacaine
Pre-Exposure Prophylaxis (Females)
5-FU
View Full List
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Belarus
Contract Research Organizations in Bulgaria
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Burundi
Contract Research Organizations in Denmark
Contract Research Organizations in Gabon
Contract Research Organizations in Hungary
Contract Research Organizations in Liberia
Contract Research Organizations in Macedonia
Contract Research Organizations in Slovenia
Contract Research Organizations in Switzerland
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Sweden
OPIS
Scandinavian CRO
Astrom Research International
RTI Health Solutions
ProPharma Group
Accium Biosciences
IQVIA
ICON
Parexel
Dokumeds
All CROs in Sweden
3